DaVita Inc. (DVA) stock
DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3044% below fair value
$174.56+0.49 (+0.28%)
Close on Nov 13, 2026Market cap $10.98BP/E 12.9Yield –
DaVita r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for DaVita
DaVita has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?